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Abstract 
The bone chamber implant (BCI) has allowed 
monitoring a healing bone defect as well as the effect 
of an eroding implant on the healing process. The 
BCI is a useful tool and intravital microscopy a 
valuable technique for obtaining quantitative data 
chronicling osseous wound healing. The physiological 
parameters that form the initial data base documen-
ting healing are neo-osteogenesis and neo-angiogene-
sis. This review compares and characterizes osseous 
wound healing in a BCI loaded with an erodible 
copolymer, PLGA (polylactide-polyglycolide). To 
determine if a statistically significant deviation from 
normal healing had occurred, the results were com-
pared with present and historical controls. In the 
BCI PLGA erosion was accompanied by a delay in 
the onset of neo-osteogenesis, as measured by trabec-
ular apposition. Concurrently, neo-angiogenesis was 
both detained and retarded. The neo-angiogenesis 
delay was interpreted as a direct consequence of the 
neo-osteogenesis delay since the major part of the 
vasculature was carried by the apposing trabeculae. 
Angiogenesis inhibition is more difficult to interpret 
until data are further analyzed to determine if ap-
posing trabeculae in the presence of eroding PLGA 
carry less vasculature. 
Key Words: Bio-erodible implants, polylactide-poly-
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Introduction 
A goal of orthopaedic surgery is the restoration 
of traumatized bone to a functioning status. Where 
trauma results in fractures, fixation devices are often 
required. Where radical resection of tumors or 
infected bone leaves a large defect, reconstruction 
requires grafting procedures using a range of implant 
materials, from vascularized autogenous bone to 
ceramics. If the implant is sufficiently tolerated to 
induce no worse than a sequestrum and the bone 
returns to an acceptable level of function, no further 
surgery is necessary. However, neither allogeneic nor 
autogeneic bone implants are ideal (Hollinger & 
Battistone, 1986) and many implants must be sur-
gically removed. For reconstructions, revision may be 
necessitated by complications such as osteomyelitis. 
Fixators, in contrast, are prophylactically removed to 
preclude stress-shielding-induced resorption, among 
other complications. 
Erodible implants have the theoretical potential 
to be replaced by host bone while they gradually shift 
mechanical stress to regenerating bone. They must, 
however, be osteoconductive, which is to say they 
must encourage bone to occupy the space created by 
their degradation quickly enough to maintain load 
transfer continuity and/or prevent soft tissue prolapse. 
Failure to do so in loaded bone would invite fracture. 
They also must be biocompatible, to the extent that 
they generate no significant foreign-body reaction. 
To be sure, "There is no such thing as an inert 
implant material or device. At best the host tissues 
will benignly tolerate an implant" (Bloch, 1984). 
For almost 30 years, erodible polymers have been 
used, initially as "absorbable" sutures and more 
recently for orthopaedic fixation (Zhang et al., 1993) 
and reconstruction in place of metallic plates/screws, 
allogeneic/autogeneic bone or other erodible materi-
als (Gilding & Reed, 1979; Visscher et al., 1985). 
The clinical rationale is that revision surgery will be 
unnecessary. Furthermore, erodible polymers would 
not be expected to elicit an antigenic response. 
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Indeed, it is often assumed that the degrading poly-
mer will induce no foreign-body reaction. 
Aliphatic polyesters such as polylactide (PLA, in 
combination) and polyglycolide (PGA, alone or in 
combination) have been used widely as erodible su-
tures. Rokannen and his colleagues have applied 
various formulations of PLA and PGA in over 1600 
orthopaedic fixations, taking advantage of their range 
of mechanical properties (Daniels et al., 1990). This 
range may be extended by forming copolymers of the 
two aliphatics in various molar ratios (e.g. 50:50 or 
90:10). The resulting poly-L-lactide-glycolide 
(PLGA) can then undergo post-synthesis manipula-
tion to further alter its degradation profile (Lewis, 
1990). Consequently, based upon its chemical flexibi-
lity and successes in previous investigations (Ho-
llinger, 1983; Hollinger & Battistone, 1986; Hollinger 
& Smitz, 1987), PLGA was the polymer of choice for 
the investigations reviewed here. It was expected that 
a 50:50 LA:GA composition would combine the 
mechanical strength of polyglycolide (Daniels et al., 
1990) with the erosion stability of poly-L-lactide 
(Lewis, 1990). 
Biocompatibility of these polymers in orthopaedic 
application has been called to question recently by 
reports of clinical non-specific aseptic foreign-body 
reactions (BOstman et al. , 1991) and in vitro toxicity 
(Daniels et al., 1992). Accordingly, it was necessary 
to examine the interaction of PLGA implants and 
bone, using the BCI and intravital microscopy. Incor-
poration (the replacement of an implant by regener-
ating host bone) in the tissue was quantitated. 
The project goal was to chronicle the appearance 
of specific tissues (trabeculae and vessels) in the BCI, 
thereby advancing understanding of the incorporation 
process. 
Intravital Microscopy for 
Observation of Incorporation 
Clinical studies do not allow one to follow the 
interaction of polymer and host bone under con-
trolled conditions. In vitro studies do not recreate the 
dynamics of interstitial fluid exchanges and in vivo 
studies usually have been restricted to assessing har-
vested tissue. By implanting a BCI which acts as an 
in situ window to the incorporation focus, it is pos-
sible to follow the interaction of bone and polymer as 
cause and effect. 
Optical bone chamber intravital microscopy 
provides the necessary window. The bone chamber 
implant (BCI) is a descendent of Sandison's (1924) 
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rabbit ear chamber. It was developed by Brflnemark 
(Brflnemark et al., 1964) and refined by Albrektsson 
and Albrektsson (1978) and McCuskey et al. (1971). 
It is a bicortical tibial screw which houses a chamber 
bounded on two sides by parallel, optically flat fused-
silica elements, between which healing tissue may be 
observed as it converts from fibrovascular tissue to 
bone (Winet, 1989). The elements are lOOµm apart. 
Histological studies using the BCI have been reviewed 
by Albrektsson (1987). The present review focuses on 
the quantitative chronic studies from the Bone Cham-
ber Laboratory of Orthopaedic Hospital (OH-BCL) 
which have been conducted since 1986 and more 
recent work at USAIDR (U.S. Army Institute of 
Dental Research). 
The components of the BCI are shown in Figure 
1. They were glued together with blackened surgical 
grade silastic (RTV) and the unit sterilized with 
ethylene oxide at room temperature as described 
previously (Winet & Hollinger, 1993). Nineteen 
mature (>6 months old) male and female New 
Zealand White rabbits were utilized. They were all at 
least 4kg (Winet & Hollinger, 1993). Bicortical 
implantation followed irrigated burring at 1500 rpm 
and tapping. Both implantation and exposure surger-
ies, which occurred 20 days post-implantation (D20), 
were aseptic and accompanied by an antibiotic proto-
col. The three-week delay allowed for osseointegra-
tion of the implant. Pin-tract infection post-exposure 
was prevented by daily lavage. 
Observations began three weeks (W3=D21) post-
implantation and continued weekly until W8 or later. 
They were performed on a horizontal intravital 
microscope as shown in Figure 2. The microscopic 
field-of-view revealed a 2mm circle in the window. 
The image was termed a "slit-gap field-of-view" and its 
contents the "slit-gap tissue"; boundaries formed a slit 
and extended across the gap defect. 
The field-of-view was recorded on photographic 
film and videotape. Apposition new bone ("neo-
osteogenesis") was revealed by transmitted light 
illumination. Collagen orientation and mineralization 
were assessed with transmitted, polarized light and 
oxytetracycline epifluorescence. Perfused microvas-
culature, which the BCI is uniquely able to show, and 
neo-angiogenesis were detected with epifluorescence 
of intravenous-injected microspheres (l.75µm) and 
dextran-conjugated dyes. 
Measurements from the BCI were recorded over 
time and established a quantitative "normal" healing 
baseline for neo-osteogenesis and neo-angiogenesis. 
These observations determined the control data base 
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Figure 1. Exploded view of bone chamber implant 
(BCI). At upper center is hollow titanium screw 
(30mm long), i.e. a shell. Below it are the quartz 
(fused-silica) window elements ground to optical 
flatness at each end. The quartz rod is glued into 
the tail and the cone in to the head of the BCI. At 
their interface is a lOOµm slit. The circular objects 
at the left and right are threaded buttons which 
screw on to the head or tail to keep skin reflected 
during permanent exposure for chronic viewing. 
Figure 3. Slit-gap tissue at W90 (90 weeks follow-
ing implantation). At this time there was no evi-
dence of PLGA. Bone appears to be the dominant 
tissue. Cortical lamellar bone appears to be mixed 
with fat cells which may have migrated from the 
medullary canal as they were not seen during incor-
poration. Circle of image is 2mm in diameter. 
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Figure 2 Intravital microscope observation 
through the BCI. B= part of leg carrying BCI; C= 
microscope condenser for transmitted light; F= 
rabbit's foot; H= location of rabbit's head. 0= 
microscope objective turret (Objective in same 
optical axis as BCI is about 1/2 the distance bet-
ween 'B' and 'O'); Y = top of yoke which aligns and 
holds BCI in same optical axis as objective. 
(Winet et al., 1990ab). Bone apposition was ex-
pressed as change in per cent of slit-gap field oc-
cupied by apposing trabeculae (6.%B) with time. 
Angiogenesis was expressed as vessel length per unit 
volume of matrix bone and/or fibrovascular tissue 
(LN) as a function of time. 
There was concern that rigidity of the titanium 
shell of the BCI would stress-shield the slit-gap tissue, 
leading to resorption-related deviations from the 
normal healing process. Two lines of evidence have 
significantly reduced the validity of this concern. 
First, electro~inetic, not piezoelectric forces deter-
mine mineralization in bone (Otter et al, 1990). 
Consequently, fluid flow, which for bone blood vessels 
is determined more by mechanics outside (muscle 
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contraction, etc.) than inside the bone, has more 
impact on events in the BCI than do local bone 
stresses. Second, most chambers examined after over 
a year of implantation contain lamellar bone; an 
example of which is presented in Figure 3. If stress 
shielding were significant, bone would be either 
totally resorbed or would not be able to regenerate 
beyond primary osteons (i.e. woven bone). 
The BCI as a Tool for Studying PLGA Incorporation 
Traditional studies of PLGA incorporation have 
been histological. Few have applied quantitative 
methods to study bone defects filled with PLGA 
plugs and harvested at various time intervals to assess 
the changes in cell and tissue populations (Hollinger, 
1983). Bone apposition was quantitatively and vas-
cularity qualitatively evaluated in these studies. Re-
sults indicated a PLGA-generated enhancement of 
bone healing (Hollinger, 1983). 
Nevertheless, it was hypothesized for the BCI 
study that /J. %B/t would not be altered by PLGA 
erosion. It was reasoned that in the Hollinger stud-
ies, healing rat bone tissue was able to use the PLGA 
plug as a scaffolding. Moreover, the intimate contact 
between bone and plug shortened the distance in-
vading vessels had to traverse with their acid-buffering 
plasma. In the BCI there was a space of about lmm 
between the perimeter of the bur-hole and the 
PLGA-the total defect diameter was 4mm-that 
would probably serve as a reservoir for the accumula-
tion of lactic and glycolic acid until blood vessels 
could cross into the slit-gap field-of-view. The form 
of 40kDa PLGA used was a lOOµm diameter thread, 
a poor scaffolding candidate in a 2mm-wide tissue, 
even when penetrated by advancing vessels. The 
interaction of PLGA with tissue was postulated, 
consequently, to be more chemical than mechanical. 
Thus, it was postulated that the acidic monomers of 
PLGA degradation could accumulate in the reservoir 
sufficiently to inhibit neo-osteogenesis from the 
cortex. At this point the report by Vasenius et al. 
(Vasenius et al, 1992), showing that except for a point 
well after incorporation blood pH changed insig-
nificantly around polylactide intramedullary rods, had 
not appeared. 
How would polymer erosion effect the micro-
vasculature? Lactic acid is a known stimulator of 
angiogenin release from macrophages (Jensen et al., 
1986). Could PLGA degradation stimulate angiogen-
esis? Pyruvic acid, product of glycolic acid metabol-
ism has no effect on angiogenesis. Thus, copolymer 
degradation would be expected to stimulate angiogen-
esis. Neo-osteogenesis is associated with high vas-
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cularity (Heppenstall, 1980). Accordingly, PLGA 
erosion would have a positive effect on neo-osteogen-
esis via the vascular avenue. There appear to be no 
studies of the direct effect of PLGA bio-absorption 
on cytokine production. 
The two conflicting predictions suggested a 
balance between agents either that favor or inhibit 
neo-osteogenesis. Consequently, it was hypothesized 
that their effects would offset and neo-osteogenesis 
into a BCI would occur at the same rate in controls 
(i.e. , unloaded BCis) as in experimentals (i.e., BCis 
loaded with PLGA); which is, in effect the null hypo-
thesis). 
The Control Model 
In order to define a response to a foreign body, 
one must have a standard for comparison that ex-
cludes the foreign body, i.e., a control wound healing 
model for bone. Central to the establishment of such 
a model-particularly if it is to be quantitative-is 
the question of which physiological (or pathophysio-
logical) parameters give the most insight to healing 
mechanisms. This question was answered on a 
practical level. 
It was impractical to measure all physiological 
parameters in a control model, with the hope that 
one of them would be the key variable determining 
success of implant incorporation. Neo-osteogenesis 
is an obvious choice when bone is the implant site. 
As in other forms of regenerative wound healing, 
however, success of osteogenesis is determined by 
effective deployment of cells which prepare the way 
for normal osteoblast function. Among these are 
macrophages (or their other existences as monocytes 
or histiocytes), fibroblasts and endothelial cells which 
regulate each other (and themselves) with a variety of 
cytokines (D'Amore, 1991). The BCI does not permit 
sufficient optical resolution to track individual cells 
(except some in the vessels) or their secretions 
without linking cell and/or secretion to fluorescent 
molecules (This aspect of bone intravital microscopy 
is in its infancy and is a fertile ground for future 
development of the model.). Observations thus far 
have had to be limited to the tissue level, however, 
and it is this consequence of wound healing cell 
action that has characterized BCI reports. 
In the control BCI, macrophages essentially have 
completed their contribution to wound healing by W3 
(the third week post-implantation). The tissue in the 
field-of-view at this time is fibrovascular (Albrektsson, 
1987). Polarized microscopy has revealed birefrin-
gence patterns characteristic of oriented collagen 
fibers (Winet et al., 1990a), undoubtedly laid down by 
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TABLE 1. Neo-Osteogenic Parameters 
PARAMET- CONTROL EXPERIMENTAL 
ER 
First detected Between W3 and Between W4 and W5 
W4 
Maximum W8 or W9 (in Between WlO and 
ACCUMU- Bone only) W12 (B) 
LATION 
OCCUR- Between W4 and Between W7 and W8 
REN CE W5 
of Maximum 
rate 
VALUE of Ll%B = 3.6% per Ll%B = 4.3% per day 
Maximum rate day 
OCCUR- When slit -gap is When slit-gap is filled 
REN CE filled 
of Minimum 
rate 
VALUE of Apparently Zero Apparently Zero when 
Minimum rate when slit -gap is slit-gap is filled 
filled 
the fibroblasts and providing the scaffolding for 
endothelial cells. Many of the vessels formed by the 
endothelial cells were sufficiently interconnected to 
sustain a pressure gradient as evidenced by flowing 
blood, made visible by intravenously-injected 70kDa 
fluorescein isothiocyanate dextran. 
Videotapes of these observations were analyzed 
using a digital image processing system. Projected 
bone area measures were converted to volume values 
by assuming a thickness equal to the slit (Each slit 
was measured following chamber construction.). By 
a similar procedure, vessel length was obtained from 
fluorescent images and expressed as length per unit 
volume (LN) of encompassing tissue. 
"Neo-osteogenesis" and "neo-angiogenesis" obser-
vations from the control and experimental BCis are 
summarized in Tables 1 and 2. The prefix "neo" is 
used as the regenerating tissue is entering a "new" 
space, the bone chamber, while at the same time 
refilling an old space (the bone defect). "Angio-
genesis" is used in place of "vascularization" because 
the mechanism of healing, as opposed to a mere 
description of structure, is the main interest. The 
control data, summarized in the Tables have been 
reported (Winet et al., 1990ab ). 
Trabeculae were usually detectable between W4 
and W5. The slope of neo-osteogenesis plot, ex-
pressed as percent of slit-gap filled per day, reached 
a maximum of 3.6% at this time. Between W8 and 
W9 bone was the only tissue apparent in the BCI, and 
it was assumed, based upon control data (Winet et al., 
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TABLE 2. Neo-Angiogenic Parameters 
PARAMET- CONTROL EXPERIMENT AL 
ER 
First detec- Prior to W3 Prior to W3 
ted 
Maximum 1. In fibrous tissue, no Between Wl 0 and 
ACCUMU- maximum LN Wll 
LA TI ON 2. In osseous tissue, at 
WB 
OCCUR- Between W7 and W8 Between W6 and W9 
REN CE 
of Maximum 
rate 
VALUE of LN = 3.80x106µm- LN = 5.12x1o5-
Maximum /cc per day µ m/cc per day 
rate 
OCCUR- Between W3 and W4 Between W6 and W9 
REN CE 
of Minimum 
rate 
VALUE of LN decreases 2.42- LN decreases 2. 73-
Minimum x 106 µ m/cc per day x 1 o5 µ m/cc per day 
rate 
1990a), to be the only tissue present. 
The vessels observed were not the same from 
week to week. It was unusual to be able to identify 
a vessel at one week that was clearly the same vessel 
observed the week before. Thus, the neo-angiogene-
sis described herein is not a simple lengthening of 
vessels. It may well be the net effect of vessel sprout-
ing and resorption. The term 'neo-angiogenesis' in 
this model at least, must be understood within the 
limits of these considerations, and the fact that only 
perfused vessels were measured. Neo-angiogenesis 
followed a pattern not previously reported for bone. 
Post-traumatic hyperemia, characteristic of the 
inflammatory phase of wound healing was evidently 
accompanied by high vascularization and perfusion in 
the slit-gap fibrovascular tissue. As these vessels were 
resorbed, LN decreased, an effect still in progress at 
W3. Accordingly, a descending curve of LN vs time 
was typical between W3 and W4. Maximum neo-an-
giogenesis occurred between W7 and W8. A com-
parison of invading trabeculae with their host fibro-
vascular matrix showed that this LN increase was 
contributed by the ossified component. In this model, 
at least, apposing bone brings blood to the healing 
tissue. When perfused vasculature was not extensive, 
bone apposition was high. As apposition leveled off 
to a zero rate-with remodeling replacing model-
ing-neo-angiogenesis decreased. 
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Figure 4. Neo-osteogenesis, neo-angiogenesis and 
PLGA erosion in a bone chamber. First panel 
shows polymer pre-implantation. Other panels are 
vertical pairs of brightfield and fluorescent images. 
Times (W3, etc.) are in weeks post-implantation. 
Polymer (P), trabeculae (B) and fibrovascular tissue 
(F) are labeled in the first brightfield row. Per-
fused vessels (PV) are parallel with the bone long 
axis. WlO is represented with two fluorescent pho-
tographs with the brightfield image replaced by ox-
ytetracycline deposition at mineralization sites (ar-
row) and regions from which it has not yet diffused 
(photograph taken less than 4 days after injection). 
The Experimental Model 
Neo-osteogenic response to PLGA in the BCI has 
been reported (Winet & Hollinger, 1993). One of 
the first discoveries was an apparent rapid degrad-
ation in a small but significant number of polymer 
strands in vivo. This result was attributed to the 
existence of highly amorphous sections of the copoly-
mer and serves as an indicator of variability in the 
syntheses of these polyesters. No healing occurred in 
these bone chambers. 
278 
15.0 
13.5 
12.0 
... 
10.5 
E 
u 9.0 
' E :t. 7.5 
..... 
a 
~ 
6.0 
> 
' 
... 5 _. 
3.0 
1.5 
0.0 
3 .. 5 6 7 8 9 10 11 
WEEKS POST-IMPLANTATION 
12 
t.O 
0.9 
0.8 
0.7 
0.6 
c 
0 
0.5 ~ 
0 
o ... &!:: 
0.3 
0.2 
O.t 
0.0 
Figure 5. Summary of measurements of neo-os-
teogenesis and neo-angiogenesis in control and 
experimental subjects, and PLGA erosion in the 
latter. Vascularity is defined as perfused vessel 
length per unit tissue volume. Ossification is 
fraction of slit-gap field-of-view filled with trabe-
culum. Error bars are omitted for clarity, but may 
be found in original reports. The control bone 
regression curve has been continued well beyond 
W9 (the final observation point if beyond W8) for 
symmetry. Note that neo-osteogenesis is delayed 
and neo-angiogenesis is both delayed and inhibi-
ted around the eroding PLGA. 
Results from the more typical specimens are de-
picted in Figure 4. Data from these observations are 
summarized in Tables 1 and 2 and Figure 5. Trabec-
ulae usually appeared at W5, occasionally being de-
layed to W6 or W7. Osseous filling of the slit-gap 
was rarely achieved before WlO and the maximum 
neo-osteogenic rate occurred between W7 and W8. 
The delay in comparison with the controls was stat-
istically significant between W5 and W9. After this 
delay, however, osteogenesis, as indicated by the curve 
slope, proceeded at the same rate as the controls. An 
apparent 'recovery' of osteogenesis after W5 produced 
apposition rates as high as 4.3%, a value 20% higher 
than the fastest control rate. Such accelerations were 
not, however, sufficiently characteristic to generate a 
steeper regression curve (Figure 5). 
There was no evidence of incompatibility between 
trabeculae and polymer. It appeared that the regen-
erating bone interfaced directly with the polymer 
(Figure 4). Confirmation of this observation at the 
cellular level awaits further histological study. 
Neo-angiogenesis analysis is still in preliminary 
stages but it was apparent that LN vs time was 
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delayed in the presence of PLGA. Maximum per-
fused vascularity occurred between WlO and Wl l, 
three weeks after the control peak. Neo-angiogenesis 
was depressed, with the minimum LN value almost 
halved (Figure 5). Nevertheless, the pattern of neo-
angiogenesis persisted, including a projected maxi-
mum LN prior to W3. Probable linkage of the vas-
cular and bone results is supported by recent observa-
tions of Brighton et al. (1991 ), that osteogenesis is 
enhanced by low and collagen synthesis by high Po2. 
At this time separate evaluation of trabecular and fib-
rovascular LN has not been performed. It appears, 
however, that while the delay in neo-angiogenesis can 
be explained as an effect of trabecular apposition de-
lay, the cause of its inhibition is more elusive. Fur-
ther analysis will be necessary to determine if vascu-
larity in the trabeculae has significantly changed in 
the presence of eroding PLGA. 
No correlation could be found between the disap-
pearance of PLGA and rate of neo-osteogenesis or 
neo-angiogenesis. The plots in Figure 5 suggest a 
negative correlation between bone apposition and 
polymer erosion. If the study had been performed us-
ing acute observations, a statistically significant link-
age would have calculated. The advantage of a chron-
ic model like the BCI, is that each rabbit serves as its 
own reference. Resulting correlations were, accor-
dingly, animal-specific and, consequently, a more ac-
curate reflection of cause-and-effect. 
Biocompatibility appeared to be supported by 
neo-angiogenesis patterns. There was often evidence 
of vessel penetration of polymer fractures (Figure 4). 
Nevertheless, neo-osteogenic and neo-angiogenic de-
lay during PLGA erosion was significant. There is an 
apparent paradox between this circumstantial rela-
tionship and the lack of correlation between the dis-
appearance of PLGA and rates of the two regenera-
tion processes cited above. The paradox may be re-
solved by postulating that one of the two apparently 
time-dependent processes is not truly time-dependent. 
Since tissue regeneration is demonstrably time-depen-
dent (Winet et al., 1990ab), the candidate must be the 
PLGA. A scenario in which the visible erosion of po-
lymer is not representative of the actual loss of mass 
is not difficult to fashion for bulk eroders such as 
PLGA. Visible erosion readings are based on chan-
ges in the polymer's profile. Bulk eroders degrade in-
ternally before their outer boundary, which apparently 
acts like a semi-permeable membrane (Vert et al., 
1992), shows any sign of absorption. Accordingly, 
monomer efflux through the 'membrane' which results 
in polymer weight loss and may influence tissue 
regeneration, is not reflected in visible polymer 
surface changes. This shortcoming of the BCI model 
may be surmounted by incorporating into polymer 
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structure a covalently bound fluorescent dye which 
would be released only by depolymerization. 
The retardation of bone and vessel regeneration 
did not appear to be caused by the mere geometry of 
a foreign object in the slit-gap field, because there 
was sufficient room for both vessels and bone before 
either contacted the polymer surface. Moreover, a 
persistent effect would have diminished, rather than 
delayed, the two regenerations. The fact that neo-
osteogenic rates 'recovered' following their delay and 
neo-angiogenic plots retained their two-peaked 
pattern, supports the conclusion that normal homeo-
static wound healing mechanisms were intact in the 
slit-gap tissue. Although the PLGA strands were too 
small to pressure the surrounding tissue when expan-
ding, they could have generated crystalline "wear" par-
ticles during erosion. Accordingly, there remain 
mechanical effects which cannot be ruled out. 
Of the possible chemical effects, acidosis is not 
supported by recent observations on PLA in vivo (Va-
senius et al., 1992) and PLGA in vitro (Li et al., 
1990). However, pH in the PLA study was measured 
in nearby blood vessels rather than near the eroding 
surface. Thus, there is as yet no accounting for rel-
atively unbuffered, truly local effects. In the present 
study the expected stimulation by lactic acid mono-
mers of neo-angiogenesis did not materialize. A re-
duction of macrophages by W3 may have been the 
reason. In any case, bio-incompatibility-much less 
toxicity-did not appear to be a significant factor in 
these studies. This concurs with other rabbit studies 
(Vasenius et al, 1992). Specific chemical interactions 
yet to be investigated include the role of blood-borne 
agents and their rate of delivery on the erosion pro-
cess. Accordingly, analysis of permeability and blood 
supply in the BCI-PLGA model are currently in prog-
ress to obtain insight into the transport aspects of the 
incorporation of this copolymer. 
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PLGA Effect on Regeneration in Bone Chamber 
Discussion With Reviewers 
T.A. Einhorn: Is there any evidence that PLGA, or 
any of the other polymers currently used in the manu-
facture of resorbable sutures or implants, have a di-
rect inhibitory effect on the synthesis of any cytokines 
and growth factors produced by osteoblastic, pre-oste-
oblastic, chondroblastic and inflammatory cells? 
Authors: The short answer is that there do not 
appear to be any studies addressing the direct effect 
question in terms of synthesis. Tne long answer is 
that biocompatibility and osteoconduction have been 
the foci of both in vitro and in vivo studies. In vitro 
studies are exemplified by Laurencin's group (e.g. 
Elgendy et al.,(1993) measured alkaline phosphatase 
activity in MC3T3-El osteoblast-like cells grown in 
culture on aliphatic polyesters and polyanhydrides.) 
An in vivo counterpart would have to relate the re-
lease of monomers to a change in production of a 
given cytokine. General effects of pH, as cited in the 
present report, have been studied for a number of cy-
tokines. But, as shown by Jensen et al. (1986) who 
pinpointed lactic acid as the stimulus for macrophage 
angiogenin secretion, the specific molecule causing 
the observed effect must be known to interpret the 
data. 
Elgendy, HM, ME Norman, AR Keaton, CT 
Laurencin (1993) Osteoblast-like cell (MC3T3-El) 
proliferation on bioerodible polymers: An approach 
towards development of a bone-bioerodible polymer 
composite material Biomat. 14: 263-269. 
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